AgomAb Therapeutics NV (AGMB)
NASDAQ: AGMB · Real-Time Price · USD
14.43
+0.81 (5.95%)
At close: Mar 9, 2026, 4:00 PM EDT
14.15
-0.28 (-1.94%)
After-hours: Mar 9, 2026, 7:56 PM EDT
AgomAb Therapeutics NV Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2024 | FY 2023 | FY 2022 | FY 2019 | FY 2018 |
| Mar '26 Mar 9, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 |
| Market Capitalization | 702 | - | - | - | - | - | |
| Enterprise Value | 538 | - | - | - | - | - | |
| Debt / Equity Ratio | 0.01 | 0.01 | 0.01 | 0.00 | - | 1.50 | |
| Net Debt / Equity Ratio | -0.87 | -0.90 | -0.80 | -1.02 | -1.11 | -0.94 | |
| Net Debt / EBITDA Ratio | 2.36 | 3.54 | 3.89 | 2.99 | - | - | |
| Net Debt / FCF Ratio | 2.50 | 3.58 | 4.91 | 3.57 | - | - | |
| Quick Ratio | 13.63 | 19.02 | 12.80 | 2.39 | - | 1.67 | |
| Current Ratio | 13.99 | 19.05 | 12.81 | 2.39 | - | 1.67 | |
| Return on Equity (ROE) | - | -27.26% | -10.46% | - | -90.33% | -1901.98% | |
| Return on Assets (ROA) | - | -15.90% | -14.32% | - | -49.38% | -139.78% | |
| Return on Capital Employed (ROCE) | -34.90% | -24.30% | -19.40% | -31.80% | -41.30% | -295.40% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.